rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Katryn Blake

Director

Company insider

Files Form 4 as: Director, Twist Bioscience; Director, TripAdvisor; Director, SEMrush Holdings; Director, Ally Financial; CEO, Vistaprint, Cimpress.

In numbers

Trades disclosed
490
Buys
0
Sells
60
Bought
$0
Sold
$25.8M
Companies
5
Companies where not an officer
4
First trade
22 Nov 2010
Last trade
12 Aug 2026
Last filed
14 Aug 2026

Companies traded

Where they are an officer
CMPR CimpressOfficer · Broadcasting & cable · last 19 Nov 20180 buys · 59 sells
Everywhere else they filed: board seats, 10% stakes, other companies
TWST Twist BioscienceDirector · Genomics & Gene Editing · last 12 Aug 20260 buys · 1 sell
TRIP TripAdvisorDirector · IT Services & Consulting · last 29 Jun 20260 buys · 0 sells
SEMrush HoldingsDirector · Software · last 28 Apr 20260 buys · 0 sells
ALLY Ally FinancialDirector · Regional banks · last 7 Jan 20220 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Aug 2026filed 14 Aug 2026TWST Twist BioscienceGenomics & Gene EditingSEC FORM 4 Sold$275K2,240 at $122.88filing
12 Aug 2026filed 14 Aug 2026TWST Twist BioscienceGenomics & Gene EditingSEC FORM 4 Sold$275K2,240 at $122.88filing
29 Jun 2026filed 1 Jul 2026TRIP TripAdvisorIT Services & ConsultingSEC FORM 4 Code A—17,818 at $0.00filing
29 Jun 2026filed 1 Jul 2026TRIP TripAdvisorIT Services & ConsultingSEC FORM 4 Code A—17,818 at $0.00filing
28 Apr 2026filed 28 Apr 2026SEMrush HoldingsSoftwareSEC FORM 4 Code D$821K68,393 at $12.00filing
28 Apr 2026filed 28 Apr 2026SEMrush Holdingsoption or derivative · SoftwareSEC FORM 4 Code D—60,000filing
28 Apr 2026filed 28 Apr 2026SEMrush Holdingsoption or derivativeSEC FORM 4 Code D—60,000filing
28 Apr 2026filed 28 Apr 2026SEMrush HoldingsSEC FORM 4 Code D$821K68,393 at $12.00filing
5 Feb 2026filed 9 Feb 2026TWST Twist BioscienceGenomics & Gene EditingSEC FORM 4 Code A—5,095 at $0.00filing
5 Feb 2026filed 9 Feb 2026TWST Twist BioscienceGenomics & Gene EditingSEC FORM 4 Code A—5,095 at $0.00filing
5 Aug 2025filed 7 Aug 2025TWST Twist BioscienceGenomics & Gene EditingSEC FORM 4 Code A—14,353 at $0.00filing
18 Jun 2025filed 1 Jul 2026TRIP TripAdvisorIT Services & ConsultingSEC FORM 4 Code A—19,171 at $0.00filing
18 Jun 2025filed 1 Jul 2026TRIP TripAdvisorIT Services & ConsultingSEC FORM 4 Code A—19,171 at $0.00filing
18 Jun 2025filed 20 Jun 2025TRIP TripAdvisorIT Services & ConsultingSEC FORM 4 Code A—19,171 at $0.00filing
11 Jun 2024filed 13 Jun 2024TRIP TripAdvisorIT Services & ConsultingSEC FORM 4 Code A—13,616 at $0.00filing
6 Jun 2023filed 8 Jun 2023TRIP TripAdvisorIT Services & ConsultingSEC FORM 4 Code A—15,105 at $0.00filing
14 Jun 2022filed 16 Jun 2022TRIP TripAdvisorIT Services & ConsultingSEC FORM 4 Code A—12,800 at $0.00filing
7 Jan 2022filed 11 Jan 2022ALLY Ally FinancialRegional banksSEC FORM 4 Code A—683 at $0.00filing
7 Oct 2021filed 12 Oct 2021ALLY Ally FinancialRegional banksSEC FORM 4 Code A—637 at $0.00filing
9 Jul 2021filed 12 Jul 2021ALLY Ally FinancialRegional banksSEC FORM 4 Code A—653 at $0.00filing

News

Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisTWST · tickerreport.com · 15 Oct 2026

0 headlines in the last 90 days name Katryn Blake; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Communications59
Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Florian BaumgartnerEVP and CEO, Vista · EVP and CEO, Vista at Cimpress, filing Form 4 there in the last year
Robert S. KeaneCEO, Chairman · CEO, Chairman at Cimpress, filing Form 4 there in the last year
Maarten WensveenEVP & Chief Technology Officer · EVP & Chief Technology Officer at Cimpress, filing Form 4 there in the last year
Sean Edward QuinnEVP, Chief Financial Officer · EVP, Chief Financial Officer at Cimpress, filing Form 4 there in the last year
Wayne Hsing-Yuan TingChief Executive Officer · Director at Cimpress, filing Form 4 there in the last year
Adam LaponisChief Financial Officer · Also traded TWST in the last 90 days
Emily M. LeproustChief Executive Officer · Also traded TWST in the last 90 days
Dennis ChoOfficer · Also traded TWST in the last 90 days